MY Stock MarketDetailed Quotes
7081 PHARMA
- 0.430
- -0.010-2.27%
15min DelayNot Open Jul 16 16:35 CST
619.73MMarket Cap-10000P/E (TTM)
0.445High0.420Low3.45MVolume0.440Open0.440Pre Close1.49MTurnover0.51052wk High0.70%Turnover Ratio1.44BShares0.29552wk Low-0.043EPS TTM212.37MFloat Cap1.267Historical HighLossP/E (Static)493.88MShs Float0.067Historical Low-0.059EPS LYR5.68%Amplitude--Dividend TTM-2.28P/B100Lot Size--Div YieldTTM
PHARMA Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.60%964.96M | -2.20%3.4B | -8.45%789.81M | -1.06%885.49M | 11.51%848.73M | -8.49%880.45M | -27.71%3.48B | 21.22%862.72M | -58.04%894.94M | -35.34%761.1M |
| Cost of revenue | 7.04%841.65M | -16.09%3.1B | -41.64%783.39M | -6.10%775.22M | 11.16%751.76M | -7.10%786.29M | -11.82%3.69B | 142.01%1.34B | -55.33%825.59M | -37.35%676.27M |
| Gross profit | 30.95%123.31M | 246.87%307.82M | 101.34%6.42M | 59.01%110.27M | 14.30%96.97M | -18.69%94.17M | -133.27%-209.59M | -405.32%-479.58M | -75.62%69.35M | -13.16%84.84M |
| Operating expense | -6.11%67.84M | 4.33%328.01M | -70.82%28.79M | 104.03%151.01M | 6.94%75.94M | 2.21%72.26M | -2.46%314.39M | 291.71%98.66M | -57.77%74.02M | 5.03%71.02M |
| Selling and administrative expenses | ---- | 4.31%328.27M | ---- | ---- | ---- | ---- | -2.46%314.72M | ---- | ---- | ---- |
| -General and administrative expense | ---- | 4.31%328.27M | ---- | ---- | ---- | ---- | -2.46%314.72M | ---- | ---- | ---- |
| Other operating expenses | -6.11%67.84M | ---- | ---- | 104.03%151.01M | 6.94%75.94M | 2.21%72.26M | ---- | ---- | -57.77%74.02M | 5.03%71.02M |
| Total other operating income | ---- | -21.15%261K | ---- | ---- | ---- | ---- | -2.65%331K | ---- | ---- | ---- |
| Operating profit | 153.19%55.47M | 96.15%-20.19M | 96.13%-22.37M | -772.34%-40.75M | 52.14%21.03M | -51.44%21.91M | -270.28%-523.97M | -538.43%-578.24M | -104.28%-4.67M | -54.04%13.82M |
| Net non-operating interest income (expenses) | -27.13%-16.93M | -54.28%-60.37M | -29.96%-15.96M | -64.90%-15.85M | -62.65%-15.23M | -69.30%-13.32M | -23.04%-39.13M | -67.50%-12.28M | 12.76%-9.61M | -14.96%-9.37M |
| Non-operating interest income | -32.13%450K | 62.31%1.48M | 30.25%310K | 184.13%358K | -33.64%146K | 103.37%663K | -40.25%910K | -57.73%238K | -78.57%126K | -8.33%220K |
| Non-operating interest expense | 24.32%17.38M | 54.46%61.84M | 29.97%16.27M | 66.44%16.21M | 60.44%15.38M | 70.66%13.98M | 20.15%40.04M | 58.57%12.52M | -16.10%9.74M | 14.30%9.59M |
| Net investment income | 2,583.33%1.13M | -95.47%42K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 101.72%864K | -70,836.62%-50.22M | ||||||||
| Less:Impairment of capital assets | ---- | --0 | ---- | ---- | ---- | ---- | --50.27M | ---- | ---- | ---- |
| Less:Other special charges | ---- | -1,594.12%-864K | ---- | ---- | ---- | ---- | 28.17%-51K | ---- | ---- | ---- |
| Less:Write off | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | -15.54%511K | -85.26%397K | -147.53%-1.1M | 160.00%338K | 720.90%550K | 216.75%605K | 1,532.73%2.69M | 594.85%2.31M | 41.30%130K | -79.19%67K |
| Income before tax | 324.71%39.04M | 87.20%-78.16M | 94.14%-37.44M | -297.51%-56.26M | 40.28%6.34M | -75.45%9.19M | -320.37%-610.59M | -610.36%-638.4M | -114.41%-14.15M | -79.68%4.52M |
| Income tax | 100.17%12.87M | -96.60%581K | -145.71%-2.65M | -678.83%-7.21M | 11.39%4.02M | -25.12%6.43M | -83.73%17.07M | -85.47%5.8M | -101.93%-926K | -56.83%3.61M |
| Net income | 846.46%26.18M | 87.45%-78.74M | 94.60%-34.79M | -270.81%-49.05M | 154.27%2.32M | -90.41%2.77M | -464.48%-627.65M | -856.41%-644.2M | -126.28%-13.23M | -93.42%914K |
| Net income continuous operations | 846.46%26.18M | 87.45%-78.74M | 94.60%-34.79M | -270.81%-49.05M | 154.27%2.32M | -90.41%2.77M | -464.48%-627.65M | -856.41%-644.2M | -126.28%-13.23M | -93.42%914K |
| Noncontrolling interests | 351.69%533K | -37.54%1.42M | 232.64%642K | -61.58%292K | 89.06%363K | -89.48%118K | 4,021.82%2.27M | 162.26%193K | 55.42%760K | 4.35%192K |
| Net income attributable to the company | 868.50%25.65M | 87.27%-80.16M | 94.50%-35.43M | -252.75%-49.34M | 171.61%1.96M | -90.45%2.65M | -465.91%-629.92M | -853.89%-644.39M | -128.07%-13.99M | -94.73%722K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 868.50%25.65M | 87.27%-80.16M | 94.50%-35.43M | -252.75%-49.34M | 171.61%1.96M | -90.45%2.65M | -465.91%-629.92M | -853.89%-644.39M | -128.07%-13.99M | -94.73%722K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 790.00%0.0178 | 87.81%-0.0586 | 94.86%-0.0253 | -242.99%-0.0367 | 150.00%0.0015 | -90.57%0.002 | -465.70%-0.4809 | -853.29%-0.4919 | -128.08%-0.0107 | -94.29%0.0006 |
| Diluted earnings per share | 790.00%0.0178 | 87.81%-0.0586 | 94.86%-0.0253 | -242.99%-0.0367 | 150.00%0.0015 | -90.57%0.002 | -465.70%-0.4809 | -853.29%-0.4919 | -128.08%-0.0107 | -94.29%0.0006 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 53.33%0.069 | -70.00%0.006 | -66.67%0.005 | 0.00%0.008 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
MY
Overall
Symbol
Latest Price
%Chg